TY - JOUR
T1 - Germline sequencing identifies rare variants in finnish subjects with familial germ cell tumors
AU - Crowgey, Erin L.
AU - Soini, Tea
AU - Shah, Nidhi
AU - Pauniaho, Satu Liisa
AU - Lahdenne, Pekka
AU - Wilson, David B.
AU - Heikinheimo, Markku
AU - Druley, Todd E.
N1 - Funding Information:
The authors acknowledge grant support to MH via Sigrid Jusélius Foundation, Leukemia Research Foundation of Delaware and the National Institute of General Medical Sciences of the National Institutes of Health grant number U54-GM104941 (PI: Binder-Macleod) for supporting ELC, and the Kellsie’s Hope Foundation to TED.
Funding Information:
The authors would like to thank the families for participating in this research effort. Furthermore, the authors acknowledge support from the McDonnell Genome Institute at Washington University for conducting the next-generation sequencing, and Krishna Kanchi for providing bioinformatics support for the raw data.
Funding Information:
The authors would like to thank the families for participating in this research effort. Furthermore, the authors acknowledge support from the McDonnell Genome Institute at Washington University for conducting the next-generation sequencing, and Krishna Kanchi for pro-viding bioinformatics support for the raw data. The authors acknowledge grant support to MH via Sigrid Jus?lius Foundation, Leukemia Research Foundation of Delaware and the National Institute of General Medical Sciences of the National Institutes of Health grant number U54-GM104941 (PI: Binder-Macleod) for supporting ELC, and the Kellsie?s Hope Foundation to TED.
Publisher Copyright:
© 2020 Crowgey et al.
PY - 2020
Y1 - 2020
N2 - Purpose: Pediatric germ cell tumors are rare, representing about 3% of childhood malig-nancies in children less than 15 years of age, presenting in neonates or adolescents with a greater incidence noted in older adolescents. Aberrations in primordial germ cell prolifera-tion/differentiation can lead to a variety of neoplasms, including teratomas, embryonal carcinoma, choriocarcinoma, and yolk sac tumors. Patients and Methods: Three Finnish families with varying familial germ cell tumors were identified, and whole-genome sequencing was performed using an Illumina sequencing platform. In total, 22 unique subjects across the three families were sequenced. Family 1 proband (female) was affected by malignant ovarian teratoma, Family 2 proband (female) was affected by sacrococcygeal teratoma with yolk sac tumor in the setting of Cornelia de Lange syndrome, and Family 3 proband (male) was affected by malignant testicular tera-toma. Rare variants were identified using an autosomal recessive or de novo model of inheritance. Results: For family 1 proband (female), an autosomal recessive or de novo model of inheritance identified variants of interest in the following genes: CD109, IKBKB, and CTNNA3, SUPT6H, MUC5AC, and FRG1. Family 2 proband (female) analysis identified gene variants of interest in the following genes: LONRF2, ANO7, HS6ST1, PRB2, and DNM2. Family 3 proband (male) analysis identified the following potential genes: CRIPAK, KRTAP5-7, and CACNA1B. Conclusion: Leveraging deep pedigrees and next-generation sequencing, rare germline variants were identified that were enriched in three families from Finland with a history of familial germ cell tumors. The data presented support the importance of germline mutations when analyzing complex cancers with a low somatic mutation landscape.
AB - Purpose: Pediatric germ cell tumors are rare, representing about 3% of childhood malig-nancies in children less than 15 years of age, presenting in neonates or adolescents with a greater incidence noted in older adolescents. Aberrations in primordial germ cell prolifera-tion/differentiation can lead to a variety of neoplasms, including teratomas, embryonal carcinoma, choriocarcinoma, and yolk sac tumors. Patients and Methods: Three Finnish families with varying familial germ cell tumors were identified, and whole-genome sequencing was performed using an Illumina sequencing platform. In total, 22 unique subjects across the three families were sequenced. Family 1 proband (female) was affected by malignant ovarian teratoma, Family 2 proband (female) was affected by sacrococcygeal teratoma with yolk sac tumor in the setting of Cornelia de Lange syndrome, and Family 3 proband (male) was affected by malignant testicular tera-toma. Rare variants were identified using an autosomal recessive or de novo model of inheritance. Results: For family 1 proband (female), an autosomal recessive or de novo model of inheritance identified variants of interest in the following genes: CD109, IKBKB, and CTNNA3, SUPT6H, MUC5AC, and FRG1. Family 2 proband (female) analysis identified gene variants of interest in the following genes: LONRF2, ANO7, HS6ST1, PRB2, and DNM2. Family 3 proband (male) analysis identified the following potential genes: CRIPAK, KRTAP5-7, and CACNA1B. Conclusion: Leveraging deep pedigrees and next-generation sequencing, rare germline variants were identified that were enriched in three families from Finland with a history of familial germ cell tumors. The data presented support the importance of germline mutations when analyzing complex cancers with a low somatic mutation landscape.
KW - Familial germ cell tumors
KW - Genomics
KW - Germline analysis
KW - Next generation sequencing
UR - http://www.scopus.com/inward/record.url?scp=85087285632&partnerID=8YFLogxK
U2 - 10.2147/TACG.S245093
DO - 10.2147/TACG.S245093
M3 - Article
C2 - 32636668
AN - SCOPUS:85087285632
SN - 1178-704X
VL - 13
SP - 127
EP - 137
JO - Application of Clinical Genetics
JF - Application of Clinical Genetics
ER -